Loading...
Request sample
Sign in to send a request. Suppliers are told your name, company, role and country.
- Scientific name
- -
- Active
- Collagen, Elastin, Glycosaminoglycans, Transforming Growth Factor Proteins
- Assay
- min. 88 % Total Protein
- Physical form
- Powder · Water-Soluble Form
- Dosage
- 450.0
- MOQ · lead time
- -
About this ingredient
BiovaFlex® by Biova is a water-soluble egg membrane (WSEM) ingredient designed to support joint health and connective tissue function. This naturally derived, patented ingredient contains collagen, elastin, glycosaminoglycans, and transforming growth factor proteins in physiologically relevant ratios. BiovaFlex® offers excellent solubility, low odor, mild color, and formulation flexibility, making it suitable for tablets, capsules, powders, beverages, gummies, and effervescent applications. Clinically supported actives promote joint comfort, mobility, reduced stiffness, and cartilage resilience. Manufactured in the USA under cGMP standards, it ensures consistent quality, purity, and functional performance.
Categories
Joint & bone healthSports & performance
Technology
Water Soluble Egg Membrane (WSEM)
Specification
5 parametersReproduced exactly as the manufacturer states them. A parameter the catalogue does not hold shows as a dash rather than a default.
Identity
| Parameter | Value |
|---|---|
| Active compound | Collagen, Elastin, Glycosaminoglycans, Transforming Growth Factor Proteins |
| Technology | Water Soluble Egg Membrane (WSEM) |
| Physical form | Powder · Water-Soluble Form |
Standardization
| Marker | Guaranteed level | Applies to | Test method |
|---|---|---|---|
| Total Protein | min. 88 % | - | - |
Use and handling
| Parameter | Value |
|---|---|
| Dosage studied | 450.0 |
Applications
6 formatsFormats the supplier has run at commercial scale. No inclusion levels have been supplied for this listing yet.
BeveragesCapsulesGummiesPowder BlendsStick PacksTablets
Guides that cover this
- Application guide
Formulating for joint comfort: what the ingredient landscape looks like
Boswellia, curcumin, collagen peptides and MSM all sell into joint formulations and behave nothing alike on a production line. A tour of the mechanisms, the specification traps, and where the real formulation constraints sit.